Ask AI

Mastering the Evolving Treatment Paradigm in SCLC: Expert Case Discussions to Aid Integration of Immunotherapy and Novel Targeted Therapies

Gain expert-informed strategies for effectively incorporating immunotherapy into personalized treatment plans for patients with small-cell lung cancer and addressing treatment-related adverse events through a certified on-demand webcast, ClinicalThought commentaries, and accompanying downloadable slides.

Share

Program Content

Activities

Immunotherapy for LS SCLC
Mastering the Evolving Treatment Paradigm in SCLC: Immunotherapy Transforming Care for LS-SCLC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 30, 2025

Expires: November 29, 2025

Maximizing Therapy for ES SCLC
Mastering the Evolving Treatment Paradigm in SCLC: Maximizing Therapy for ES-SCLC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 30, 2025

Expires: November 29, 2025

Future in SCLC
Mastering the Evolving Treatment Paradigm in SCLC: Charting the Course for the Future in SCLC
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: May 30, 2025

Expires: November 29, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from Amgen, Daiichi Sankyo, Inc., Jazz Pharmaceuticals, Inc. and Merck Sharp & Dohme LLC.

Amgen

Daiichi Sankyo, Inc.

Jazz Pharmaceuticals, Inc.

Merck Sharp & Dohme, LLC